Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FP6Q0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,660
Award facts
- Contract value 100% obligated
- $22,659.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,659.50 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat various inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, and is commonly prescribed within military and veteran healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply specialty medications, brand-name and generic drugs, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent performance on competitively awarded contracts across multiple therapeutic domains demonstrates its capability to meet federal military healthcare procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FP6Q0?
SPE2DB25FP6Q0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FP6Q0 worth?
The government has obligated $22,660 on SPE2DB25FP6Q0.
Is contract SPE2DB25FP6Q0 an order under another contract?
Yes. SPE2DB25FP6Q0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP6Q0 competed?
The extent of competition for SPE2DB25FP6Q0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award